DHODH-IN-23

DHODH-IN-23

• CAS Number: 1346705-53-0
• UNSPSC Description: DHODH-IN-23 (Compound A) is an orally active DHODH inhibitor that can be used for the research of cancer[1].
• Target Antigen: Dihydroorotate Dehydrogenase
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/dhodh-in-23.html
• Solubility: DMSO : 125 mg/mL (ultrasonic)
• Smiles: O=C(C1=C(C(NC2=C(C=C(C3=CC=CC(OCCCC)=C3)C=C2Cl)F)=O)C=CC=C1)O
• Molecular Weight: 441.88
• References & Citations: [1]Srikant Viswanadha, et al. Compositions comprising a dhodh inhibitor for the treatment of acute myeloid leukemia. Patent WO2021079273A1.
• Shipping Conditions: Room Temperature
• Clinical Information: No Development Reported